Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a Phase 1/2 study. Gene ...

Novo's human insulin has been largely replaced by modern insulin and next-generation insulin analogs that provide better blood sugar control---with less hypoglycemia and weight gain--than their ...

Current labeling advises matching the inhaled insulin units to the injected mealtime dose of rapid-acting insulin analog.

A synthetic, short-acting form of insulin used to treat diabetes, regular insulin is typically an injectable drug that helps regulate blood sugar levels.

MannKind Corporation announces positive inhaled insulin data presentations and anticipates pediatric sNDA filing for Afrezza in 2025.

Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar product approved by the FDA.

The insulin glargine products are long-acting human insulin analogs, which generally take around 1-2 hours to start lowering blood sugar and then maintain a steady insulin level, whereas insulin ...

Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA.

Type 1 diabetes mellitus (T1D) is a chronic autoimmune disorder that involves the destruction of insulin-producing beta cells in the pancreas, which leads to hyperglycemia. Exogenous insulin ...

Lyumjev belongs to a group of drugs called rapid-acting human insulin analog. This article describes the dosages of Lyumjev, as well as its strengths and how to give it.